Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 21.64
+3.03 (16.28%)
Aug 5, 2026, 4:17 PM AEST
Neuren Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Neuren Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $24.13. The average 1-year stock price forecast is 11.51% higher than the current stock price, while the lowest is $19.10 (-11.74%) and the highest is $28.80 (+33.09%).
Price Target: $24.13 (+11.51%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Neuren Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains $28.80 | Buy | Maintains | $28.80 | +33.09% | Jul 29, 2026 |
Unknown Analyst Macquarie No rating | Macquarie | Buy Maintains $19.10 | Buy | Maintains | $19.10 | -11.74% | Jun 30, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $24.00 | Buy | Maintains | $24.00 | +10.91% | Jun 30, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $22.00 → $23.50 | Buy | Maintains | $22.00 → $23.50 | +8.60% | Jun 29, 2026 |
| Petra Capital | Petra Capital | Buy Maintains $29.96 | Buy | Maintains | $29.96 | +38.45% | Feb 5, 2026 |
Financial Forecast
Revenue This Year
118.41M
from 64.65M
Increased by 83.16%
Revenue Next Year
180.58M
from 118.41M
Increased by 52.50%
EPS This Year
0.37
from 0.23
Increased by 57.35%
EPS Next Year
0.57
from 0.37
Increased by 55.52%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.